GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cyanotech Corp (OTCPK:CYAN) » Definitions » Altman Z-Score

CYAN (Cyanotech) Altman Z-Score : -1.06 (As of Dec. 13, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Cyanotech Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of -1.05 is in distress zone. This implies bankruptcy possibility in the next two years.

Cyanotech has a Altman Z-Score of -1.06, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Cyanotech's Altman Z-Score or its related term are showing as below:

CYAN' s Altman Z-Score Range Over the Past 10 Years
Min: -1.05   Med: 1.6   Max: 4.18
Current: -1.05

During the past 13 years, Cyanotech's highest Altman Z-Score was 4.18. The lowest was -1.05. And the median was 1.60.


Cyanotech Altman Z-Score Historical Data

The historical data trend for Cyanotech's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyanotech Altman Z-Score Chart

Cyanotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 1.70 2.19 0.09 -0.77

Cyanotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.28 -0.77 -0.89 -0.91

Competitive Comparison of Cyanotech's Altman Z-Score

For the Packaged Foods subindustry, Cyanotech's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyanotech's Altman Z-Score Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cyanotech's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Cyanotech's Altman Z-Score falls into.



Cyanotech Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Cyanotech's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.023+1.4*-1.056+3.3*-0.1993+0.6*0.1309+1.0*0.9742
=-1.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2024:
Total Assets was $23.91 Mil.
Total Current Assets was $10.13 Mil.
Total Current Liabilities was $9.58 Mil.
Retained Earnings was $-25.25 Mil.
Pre-Tax Income was -1.15 + -1.202 + -2.076 + -1.02 = $-5.45 Mil.
Interest Expense was -0.175 + -0.161 + -0.173 + -0.172 = $-0.68 Mil.
Revenue was 5.845 + 5.898 + 5.97 + 5.582 = $23.30 Mil.
Market Cap (Today) was $1.86 Mil.
Total Liabilities was $14.22 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(10.125 - 9.575)/23.913
=0.023

X2=Retained Earnings/Total Assets
=-25.253/23.913
=-1.056

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-5.448 - -0.681)/23.913
=-0.1993

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=1.861/14.221
=0.1309

X5=Revenue/Total Assets
=23.295/23.913
=0.9742

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Cyanotech has a Altman Z-Score of -1.06 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Cyanotech  (OTCPK:CYAN) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Cyanotech Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Cyanotech's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyanotech Business Description

Traded in Other Exchanges
N/A
Address
73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, HI, USA, 96740
Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company's products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. It derives maximum revenue from the Packaged product and geographically from the United States.
Executives
Glenn Jensen officer: VP-Operations 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA-KONA HI 96740
Kakuk Collette Nicole officer: Chief Strategic Comml Officer 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Michael A / Davis director, 10 percent owner 1621 JUANITA LANE, TIBURON CA 94920
Angela May Mcelwee director 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Charles Jason Hartmann officer: VP, Sales & Marketing 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Jennifer M. Johansen officer: VP of Quality 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Walter Bennett Menzel director 45 MOUNT TIBURON ROAD, TIBURON CA 94920
Felicia I Ladin officer: CFO, VP Fin & Admin, Treasurer 26 CORPORATE CIRCLE, ALBANY NY 12203
Matthew Keith Custer officer: Vice President, Gen Mgr 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Amy Beth Nordin officer: VP, HR, Secretary 73-4460 QUEEN KAAHUMANU HWY. SUITE 102, KAILUA-KONA HI 96740
Brian Brett Orlopp officer: CFO, VP, Treasurer, Secretary 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA CA 96740
Gerald J Watts officer: COO 2530 RED HILL AVE, SANTA ANA CA 92705
Mawae Morton officer: President 7473 MAKA'A STREET, HONOLULU HI 96825
Nancy E Katz director CALYPTE BIOMEDICAL CORP, 1265 HARBOR BAY PKWY, ALAHEDA CA 94502
David M Mulder director 21771 CALATRAVA, MISSION VIEJO CA 92692

Cyanotech Headlines

From GuruFocus

Cyanotech Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 02-11-2010

Cyanotech� Corporation Launches BioAstin�

By Business Wire Business Wire 10-01-2020

Cyanotech Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 02-11-2011

Q3 2023 Cyanotech Corp Earnings Call Transcript

By GuruFocus Research 02-06-2024

Q4 2023 Cyanotech Corp Earnings Call Transcript

By GuruFocus Research 02-06-2024

Q1 2024 Cyanotech Corp Earnings Call Transcript

By GuruFocus Research 02-06-2024

Cyanotech Stock Is Estimated To Be Modestly Overvalued

By GF Value GF Value 04-01-2021

Q2 2023 Cyanotech Corp Earnings Call Transcript

By GuruFocus Research 02-06-2024